Dynamic monitoring and evaluation method for pancreatic ductal adenocarcinoma

Abstract

The invention discloses a dynamic monitoring and evaluation method for pancreatic ductal adenocarcinoma, which comprises the operation steps of S1, selecting 140 PDAC postoperative patients as test detection objects, extracting 10 milliliters of vein whole blood of each detection object before the operation and every month after the operation until the imaging progress, removing blood cells by adopting a centrifugal method to obtain serum, if the object is 4 hours away from the centrifugal treatment of the central laboratory, adopting a common blood collection tube containing ethylenediamine tetraacetic acid (EDTA) for collection, and then adopting an ice bag for transportation; and S2, selecting 1ml of serum, averagely dividing the serum into two parts, and respectively detecting two proteins. The dynamic monitoring and evaluation method for pancreatic ductal adenocarcinoma can more sensitively discover tumor relapse about 3 months earlier than imaging, bring early intervention to later treatment, bring the advantage of prolonging the life of a patient, make up for the defects based on imaging in the past, and bring better use prospects.

Description

technical field [0001] The invention relates to the biological field, in particular to a dynamic monitoring and evaluation method for pancreatic ductal adenocarcinoma. Background technique [0002] The dynamic monitoring and evaluation method of pancreatic ductal adenocarcinoma is a supporting method for postoperative examination of pancreatic cancer. It detects the patient's postoperative situation, and the model and parameters of the result meet the requirements of PDAD postoperative recurrence monitoring, and are consistent with the patient's The early screening examinations belong to different clinical application scenarios. With the continuous development of science and technology, people have higher and higher requirements for the manufacturing process of the dynamic monitoring and evaluation method of pancreatic ductal adenocarcinoma. [0003] The existing dynamic monitoring and evaluation methods for pancreatic ductal adenocarcinoma have certain disadvantages when us...

AI Technical Summary

Problems solved by technology

[0003] The existing dynamic monitoring and evaluation methods for pancreatic ductal adenocarcinoma have certain disadvantages when used. For patients after PDAC, half of the dynamic monitoring is based on imaging, the detection frequency is relatively long, the detection is not timely, and many positive The results of imaging tests of patients are not sensitive, showing false negatives, and the tumors cannot be found until the next imaging test, so the timeliness of treatment for patients is very poor, which is not conducive to people's use, and brings great harm to people's use process. Therefore, we propose a dynamic monitoring and evaluation method for pancreatic ductal adenocarcinoma

Images